Product Information
CEFPROZIL 250 MG TABLET is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.4854 per EA under NDC 68180040301. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Dec 8, 2005. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
250 mg/1
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180040301
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CEFPROZILApproval Type
Generic (ANDA)
FDA Application
ANDA065276FDA Approved
12/8/2005
TE Code
AB
On Market Since
12/1/2005
Price Statistics
The NADAC for CEFPROZIL 250 MG TABLET has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 59.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4854 per EA |
|---|---|
| All-time high | $1.5445 (Feb 12, 2014) |
| All-time low | $0.4429 (Dec 21, 2022) |
| 52-week high | $0.5890 |
| 52-week low | $0.4814 |
| Median price | $0.7394 |
| Average price | $0.7381 |
| Largest weekly change | +65.4% (Sep 22, 2021) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the CEFPROZIL market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CEFPROZIL 250 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CEFPROZIL 250 MG TABLET, manufactured by Lupin Pharmaceuticals Inc., is $0.4854 per EA (NDC 68180040301), effective Aug 19, 2026.
How has the price of CEFPROZIL 250 MG TABLET changed over time?
Over the history we have for it, the NADAC for CEFPROZIL 250 MG TABLET has declined 59.7%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CEFPROZIL 250 MG TABLET?
Since Nov 28, 2013, the NADAC for CEFPROZIL 250 MG TABLET has ranged from a low of $0.4429 (Dec 21, 2022) to a high of $1.5445 (Feb 12, 2014), with a median of $0.7394 per EA.
Are there cheaper alternatives to CEFPROZIL 250 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of CEFPROZIL 250 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CEFPROZIL 250 MG TABLET?
CEFPROZIL 250 MG TABLET (NDC 68180040301) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.